Cannabics® SR
Cancer-related Anorexia Cachexia Syndrome (CACS)
Phase 3Active
Key Facts
Indication
Cancer-related Anorexia Cachexia Syndrome (CACS)
Phase
Phase 3
Status
Active
Company
About CNBX Pharmaceuticals
CNBX Pharmaceuticals is a clinical-stage biotech company developing a pipeline of cannabinoid-based drug candidates for cancer and neuropsychiatric disorders. Its core asset, RCC-33, is positioned as a first-in-class candidate for colorectal cancer, currently in late preclinical stages preparing for an IND. The company utilizes an in-house drug discovery platform centered on high-throughput screening of cannabinoid formulations against various cancer types. Leadership combines business acumen with scientific and clinical expertise, supported by a notable advisory board in oncology.
View full company profile